STRIDE™ by IntoDNA

STRIDE™

Technology that detects DNA breaks with a precision previously unattainable by science. Game changer of precision medicine.

ABOUT THE PROJECT

How do cancer therapies affect genetic material? Traditional methods of detecting DNA damage do not accurately answer this question because they do not provide direct measurements. In the study of DNA structure, the precision of the test is crucial, so in this area the STRIDE™ by intoDNA system is a real game changer. Its exceptional sensitivity and precision sets a new standard in DNA damage detection.

DNA-Damage-Response-Functional-Assays (2)

WHAT NEEDS DOES THE INNOVATION ADDRESS?

STRIDE™ by intoDNA detects even single DNA breaks, providing previously unattainable assay sensitivity. The system allows precise measurement of both single- and double-stranded DNA breaks, which has a not inconsiderable impact on the evaluation of the repair process. With this solution, pharmaceutical companies can now tailor therapies much more effectively and make more accurate decisions.

COMPETITIVE ADVANTAGES

Through the development of new technologies intoDNA aims to replace complex genetic tests with much simpler solutions. However, the simplicity of the solution does not mean less precision – quite the opposite. The breakthrough in oncology care is accuracy, speed and accessibility. STRIDE™ opens the way to personalized therapies for every patient. This is the future of cancer treatment and the key to precision medicine.

Learn more!